“Glucose-Responsive Nanoparticles for Targeted Insulin Delivery in the Treatment of Diabetes”. 2025. Journal of Carcinogenesis 24 (4s): 914-27. https://doi.org/10.64149/J.Carcinog.24.4s.914-927.